{"id": "1361087904257372170", "creation": 1613343618.0, "user_id": "1253397714265612292", "social_network": "twitter", "nsfw": false, "request": ["1aac5aa9-16ef-4aef-93e1-0b43ea7d03cb"], "metrics": {"1aac5aa9-16ef-4aef-93e1-0b43ea7d03cb": {"retweet_count": 2, "reply_count": 0, "like_count": 3, "quote_count": 0}}, "text": "Our PICO, appraisal, and limitations for this trial looking at #favipiravir vs. #chloroquine for #COVID19 treatment.\n\n#RCT #MedTwitter #TwitteRx #clinicatrial #NurseTwitter #IDtwitter #pharmacyschool #pharmacystudent #medschool #evidencebasedmedicine #CovidRx https://t.co/rYhIOe7P0t", "first_save": 1635413522.816877, "hashtags": ["#FAVIPIRAVIR", "#CHLOROQUINE", "#COVID19", "#RCT", "#MEDTWITTER", "#TWITTERX", "#CLINICATRIAL", "#NURSETWITTER", "#IDTWITTER", "#PHARMACYSCHOOL", "#PHARMACYSTUDENT", "#MEDSCHOOL", "#EVIDENCEBASEDMEDICINE", "#COVIDRX"]}